Spurr Robert 4

4 · Bausch Health Companies Inc. · Filed Mar 2, 2022

Form 4

Period: 2022-02-26

President, Salix

Transactions

Tax Payment
Common Shares, No Par Value
2022-02-27$24.35/sh−5,646$137,480→ 70,268 total
Tax Payment
Common Shares, No Par Value
2022-02-27$24.35/sh−1,651$40,202→ 66,989 total
Exercise/Conversion
Restricted Share Units
2022-02-27$24.35/sh−15,615$380,225→ 0 total
Exercise: $24.35Exp: 2022-02-27→ Common Shares, No Par Value (0 underlying)
Exercise/Conversion
Common Shares, No Par Value
2022-02-27+15,615→ 75,914 total
Tax Payment
Common Shares, No Par Value
2022-02-26$24.35/sh−1,628$39,642→ 68,640 total
Award
Restricted Share Units
2022-02-27+15,615→ 0 total
Exp: 2022-02-27→ Common Shares, No Par Value (15,615 underlying)

Footnotes (5)

[F1]Reflects the vesting and conversion of performance-based Restricted Share Units ("PSUs"), previously granted to the reporting person, into common shares, no par value ("Common Shares") of the Issuer.
[F2]Each PSU converts into Common Shares on a one-for-one basis
[F3]This number represents Common Shares withheld to satisfy the tax withholding obligations due upon vesting of PSUs.
[F4]This number represents Common Shares withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units ("RSUs").
[F5]This number represents Common Shares withheld to satisfy the tax withholding obligations due upon vesting of RSUs.

Documents

1 file